Bayer Material-Science will be showcasing a broad spectrum of coatings products in its Baymedix portfolio, including innovative lubricious coatings and drug-eluting coatings.
Products Include Coatings, Adhesives and Semi-finished Medical Devices
Bayer MaterialScience Unites its Biomaterials Products Under the New Trade Name Baymedix
Leverkusen. Bayer MaterialScience (BMS) has launched a range of innovative biomaterials for medical devices under the new brand name Baymedix, the company will be showcasing a broad spectrum of coatings products in its Baymedix portfolio in Hall 8 of the Medtec trade show in Stuttgart from March 23-25, 2010. » more |
| The cover page of Bayer’s Sustainable Development Report. |
UN Corporate Responsibility Guidelines Compliance
Investors Praise Bayer’s Sustainability Report
Leverkusen.
A coalition of global investors from 13 countries has praised Bayer for its leadership in sustainability reporting. Their analysis revealed that Bayer’s sustainability report was of excellent quality, proved highly useful to investors and complied with the policies of the UN Global Compact, the United Nations’ corporate responsibility initiative, in which Bayer participates. » more |
WDR Broadcast “Zeitzeichen”
Carl Duisberg: 75th Anniversary of the Death of the Bayer Pioneer
Leverkusen.
Exactly 75 years ago tomorrow, on March 19, 1935, Carl Duisberg, one of the most renowned managers of his day, died in Leverkusen at the age of 73. Bayer owes a tremendous debt to its former Managing Director who, in his perpetual quest for innovation, set new standards in research and development. » more |
| The collaboration between BCS and CSIRO focuses on assessing the system-wide environmental impact of new crops. |
Agreement to Demonstrate Sustainability of New Crop Production Systems
Bayer CropScience and CSIRO Expand Research Cooperation
Monheim. Bayer CropScience (BCS) and the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia's national research agency, are expanding their collaboration to assess the sustainability of new generation crops. The two-year agreement will develop and apply models to assess the system-wide consequences of new generation cereals in the context of global environmental and food security challenges. » more |
| Cancer researcher Guido Piechowiak examines crystals in a Bayer Schering Pharma research laboratory in Berlin. |
BSP and Prometheus to Collaborate
Application of Novel Diagnostic Platform to Oncology Therapeutic Candidates
Berlin. Bayer Schering Pharma AG, Germany (BSP), has entered a research collaboration and license agreement with Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company. The collaboration partners will combine Prometheus' proprietary oncology diagnostic platform with BSP's broad oncology pipeline in an effort to stratify patients to appropriate drug candidates. » more » Audio |
| Although Baycusan contains no UV-absorbing components, the film-forming polymer raises the sun protection factor (SPF) of sample formulations. |
Polyurethane Dispersion Baycusan C 1000
For Safe Sun Protection and a Pleasant Feel to the Skin
Leverkusen. Bayer MaterialScience (BMS) will be presenting new and extensive test results giving proof of the benefits of the polyurethane raw material Baycusan C 1000 also for sunscreen formulations at the In-Cosmetics 2010 trade show in Paris from April 13 to 15. Although it contains no UV-absorbing components, the film-forming polymer raises the sun protection factor (SPF) of sample formulations, meaning that it acts as an SPF booster. » more |
| The first issue of direct global, the new e-paper for Bayer employees worldwide. |
e-paper for Bayer Employees Worldwide
Inaugural Issue of direct global
Leverkusen. The Bayer newspaper for employees in Germany, direkt, which looks back on a long history in its home country, has been published as an e-paper in English for Bayer employeed worldwide for the first time. A link to the inaugural issue was sent by email late last week. The e-paper contains stories of international significance found in the German edition of direkt as well as a summary of the previous weeks’ most important news. » more |
| At the award ceremony (front row, f. l.:) K. Tsumura, Dr. V. Stanzel, Prof. M. Aizawa, Dr. Y. Kimura, Dr. T. Inoue, Dr. F. Inn. (Second row, right: H.-D. Hausner. |
Bayer Supports Young Scientists in Japan
Winners of German Innovation Award Announced
Tokyo. The winners of the German Innovation Award, sponsored by Bayer and other German companies operating in Japan, were recently announced at a ceremony in Tokyo. A team led by Dr. Yuuji Kimura from the National Institute for Materials Science (NIMS) was honored for research into the development of stronger and tougher steel in front of an audience consisting of distinguished guests from industry, academia and politics. » more |
| Click on the picture to listen to a podcast. Pictured above are Dr. Artur Lutfullin (left) and Dr. René Rämsch. |
Treatment of Cystic Fibrosis
FDA Grants Orphan Drug Status to Ciprofloxacin Dry Powder Inhaler
Berlin. Bayer Schering Pharma AG, Germany (BSP), announced that an orphan drug designation has been granted by the U.S. Food and Drug Administration (FDA) for the ciprofloxacin dry powder inhaler (DPI) for the management of chronic pulmonary infections due to Pseudomonas aeruginosa in cystic fibrosis (CF) patients. A similar designation has already been granted by the European Medicines Agency (EMA). » more » Audio |
| Tanja Nentwig from the Charité - Universitätsmedizin in Berlin preparing an MRT. |
Bayer Starts Phase III Study with Gadovist
MR Contrast Agents for Diagnosis of Breast Cancer
Berlin. Bayer has started an international clinical Phase III study to develop its contrast agent Gadovist (gadobutrol) for use in magnetic resonance imaging (MRI) of the breast. The trial will evaluate the efficacy and safety of Gadovist in contrast-enhanced breast MRI (magnetic resonance mammography, MRM). Gadovist is already approved for the most frequently used contrast-enhanced MRI examinations including imaging of the central nervous system, the liver, the kidney and for imaging of blood vessels in adults and for the use in children aged 2 years and older. » more
Commitment to North Asean Region
Bayer Inaugurates New Office in Cambodia
Phnom Penh. Clear commitment to the country: Bayer in Cambodia has laid an important milestone with an official inauguration ceremony of its new office located in the heart of Phnom Penh. H.E. Mam Bunheng, Minister of Health in the Royal Government of Cambodia presided over the ceremony, where he was joined by German Ambassador Frank Marcus Mann, Dominikus von Pescatore, Senior Bayer Representative for North ASEAN, as well as senior executives from Bayer and the pharmaceutical industry. » more
Bayer Volunteer Day Launched
Bayer Taiwan Supports Rural Elementary School
Taipei. Bayer Taiwan has held its first Bayer Volunteer Day at Wan-Fen elementary school. Twenty-five employees from the company’s three subgroups took part in the event, where they shared their professional expertise and introduced students and their teachers to German culture and food, as part of Bayer’s leadership role in the field of corporate social responsibility. » more
Search
Bayer Search
External search
Links
-1.62%
